These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19109395)
1. Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination. Kong WP; Wu L; Wallstrom TC; Fischer W; Yang ZY; Ko SY; Letvin NL; Haynes BF; Hahn BH; Korber B; Nabel GJ J Virol; 2009 Mar; 83(5):2201-15. PubMed ID: 19109395 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. Hulot SL; Korber B; Giorgi EE; Vandergrift N; Saunders KO; Balachandran H; Mach LV; Lifton MA; Pantaleo G; Tartaglia J; Phogat S; Jacobs B; Kibler K; Perdiguero B; Gomez CE; Esteban M; Rosati M; Felber BK; Pavlakis GN; Parks R; Lloyd K; Sutherland L; Scearce R; Letvin NL; Seaman MS; Alam SM; Montefiori D; Liao HX; Haynes BF; Santra S J Virol; 2015 Jun; 89(12):6462-80. PubMed ID: 25855741 [TBL] [Abstract][Full Text] [Related]
3. Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance. Yang OO; Ali A; Kasahara N; Faure-Kumar E; Bae JY; Picker LJ; Park H J Virol; 2015 Jan; 89(2):1195-204. PubMed ID: 25378501 [TBL] [Abstract][Full Text] [Related]
4. Similar T-cell immune responses induced by group M consensus env immunogens with wild-type or minimum consensus variable regions. Weaver EA; Camacho ZT; Gao F AIDS Res Hum Retroviruses; 2010 May; 26(5):577-84. PubMed ID: 20438382 [TBL] [Abstract][Full Text] [Related]
5. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development. Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL Front Immunol; 2020; 11():984. PubMed ID: 32582155 [TBL] [Abstract][Full Text] [Related]
6. HIV Env conserved element DNA vaccine alters immunodominance in macaques. Hu X; Valentin A; Rosati M; Manocheewa S; Alicea C; Chowdhury B; Bear J; Broderick KE; Sardesai NY; Gall SL; Mullins JI; Pavlakis GN; Felber BK Hum Vaccin Immunother; 2017 Dec; 13(12):2859-2871. PubMed ID: 28678607 [TBL] [Abstract][Full Text] [Related]
7. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen. Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280 [TBL] [Abstract][Full Text] [Related]
8. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Barouch DH; O'Brien KL; Simmons NL; King SL; Abbink P; Maxfield LF; Sun YH; La Porte A; Riggs AM; Lynch DM; Clark SL; Backus K; Perry JR; Seaman MS; Carville A; Mansfield KG; Szinger JJ; Fischer W; Muldoon M; Korber B Nat Med; 2010 Mar; 16(3):319-23. PubMed ID: 20173752 [TBL] [Abstract][Full Text] [Related]
9. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques. Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820 [TBL] [Abstract][Full Text] [Related]
10. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses. Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y J Virol; 2017 May; 91(9):. PubMed ID: 28202751 [TBL] [Abstract][Full Text] [Related]
11. Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. Walsh SR; Moodie Z; Fiore-Gartland AJ; Morgan C; Wilck MB; Hammer SM; Buchbinder SP; Kalams SA; Goepfert PA; Mulligan MJ; Keefer MC; Baden LR; Swann EM; Grant S; Ahmed H; Li F; Hertz T; Self SG; Friedrich D; Frahm N; Liao HX; Montefiori DC; Tomaras GD; McElrath MJ; Hural J; Graham BS; Jin X; J Infect Dis; 2016 Feb; 213(4):541-50. PubMed ID: 26475930 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine. Yan J; Corbitt N; Pankhong P; Shin T; Khan A; Sardesai NY; Weiner DB Vaccine; 2011 Sep; 29(41):7173-81. PubMed ID: 21651948 [TBL] [Abstract][Full Text] [Related]
13. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses. Perdiguero B; Sánchez-Corzo C; Sorzano COS; Saiz L; Mediavilla P; Esteban M; Gómez CE Viruses; 2019 Feb; 11(2):. PubMed ID: 30781504 [TBL] [Abstract][Full Text] [Related]